orantinib has been researched along with tbc-11251 in 1 studies
| Studies (orantinib) | Trials (orantinib) | Recent Studies (post-2010) (orantinib) | Studies (tbc-11251) | Trials (tbc-11251) | Recent Studies (post-2010) (tbc-11251) |
|---|---|---|---|---|---|
| 110 | 19 | 36 | 167 | 32 | 58 |
| Protein | Taxonomy | orantinib (IC50) | tbc-11251 (IC50) |
|---|---|---|---|
| Endothelin receptor type B | Homo sapiens (human) | 4.9049 | |
| Endothelin-1 receptor | Homo sapiens (human) | 0.0014 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
1 other study(ies) available for orantinib and tbc-11251
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |